# INBX (Inhibrx Biosciences, Inc.) - SEC EDGAR Financial Statements

> Inhibrx Biosciences, Inc. reported $1.30M in revenue and a net loss of $141.7M for the fiscal year ended December 31, 2025 (up 550.0% year over year), with a -9671.8% operating margin.

- Canonical: https://convexityos.com/fundamentals/INBX
- Markdown: https://convexityos.com/fundamentals/INBX.md
- SEC CIK: 0002007919
- Reporting currency: USD
- Latest filing period: September 30, 2026
- Last synced: Nov 20, 2026, 05:27 UTC
- Primary source: [SEC EDGAR](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0002007919&type=&dateb=&owner=include&count=40)

## Key Financial Metrics

| Metric | Period | Value | Notes |
| --- | --- | --- | --- |
| Revenue | FY 2025 | $1.30M | +550.0% YoY |
| Operating Income | FY 2025 | -$125.7M | -9671.8% margin |
| Net Income | FY 2025 | -$141.7M | -10896.8% net margin |
| Diluted EPS | FY 2025 | -$9.01 | Split-adjusted |
| Free Cash Flow | FY 2025 | -$132.7M | -10207.6% FCF margin |
| Cash & ST Investments | Sep 30, 2026 | $199.5M | Total debt: $281.4M |

## Income Statement

### Income Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 |
| --- | --- | --- | --- |
| **Revenue** | $1.30M | $200K | $1.80M |
| Research & Development | $113.0M | $203.7M | $191.6M |
| Total Operating Expenses | $136.3M | $331.6M | $221.0M |
| **Operating Income** | -$135.0M | -$331.4M | -$219.2M |
| **EBITDA** | -$132.5M | -$329.2M | -$218.0M |
| Interest Expense | $12.20M | $13.49M | $31.84M |
| Income Before Tax | -$140.1M | $1.69B | -$239.7M |
| Income Tax Expense | $2.0K | $2.0K | $3.0K |
| **Net Income** | -$140.1M | $1.69B | -$241.4M |
| Basic EPS | -$9.04 | $114.01 | -$20.48 |
| **Diluted EPS** | -$9.04 | $112.62 | -$20.48 |
| Basic Shares Outstanding | 15.5M | 14.8M | 11.8M |
| Diluted Shares Outstanding | 15.5M | 15.0M | 11.8M |

### Income Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Revenue** | $2.00M | $0 | -- | $0 | $0 | $1.30M | $0 | $100K |
| Research & Development | $25.97M | $23.90M | $25.22M | $25.35M | $28.54M | $22.27M | $36.88M | $33.37M |
| Total Operating Expenses | $33.73M | $32.15M | $30.93M | $30.92M | $33.81M | $28.69M | $42.90M | $50.03M |
| **Operating Income** | -$31.73M | -$32.15M | -$30.93M | -$30.92M | -$33.81M | -$27.39M | -$42.90M | -$49.93M |
| **EBITDA** | -$31.22M | -$31.63M | -$30.39M | -$30.36M | -$33.23M | -$26.73M | -$42.23M | -$49.24M |
| Interest Expense | $8.75M | $5.69M | $3.51M | $3.19M | $3.18M | $3.14M | $2.69M | $0 |
| Income Before Tax | -$38.73M | -$36.65M | -$33.44M | -$32.83M | -$35.26M | -$28.65M | -$43.31M | -$47.87M |
| Income Tax Expense | $0 | $3.0K | $0 | $0 | $0 | $2.0K | $0 | $0 |
| **Net Income** | -$38.73M | -$36.65M | -$33.44M | -$32.83M | -$35.26M | -$28.65M | -$43.31M | -$47.87M |
| Basic EPS | -$2.46 | -$2.34 | -$2.15 | -- | -$2.28 | -$1.85 | -$2.80 | -- |
| **Diluted EPS** | -$2.46 | -$2.34 | -$2.15 | -- | -$2.28 | -$1.85 | -$2.80 | -- |
| Basic Shares Outstanding | 15.7M | 15.7M | 15.6M | -- | 15.5M | 15.5M | 15.5M | -- |
| Diluted Shares Outstanding | 15.7M | 15.7M | 15.6M | -- | 15.5M | 15.5M | 15.5M | -- |

## Balance Sheet

### Balance Sheet (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 |
| --- | --- | --- | --- |
| Cash & Cash Equivalents | $124.2M | $152.6M | $277.9M |
| **Cash & Short-Term Investments** | $124.2M | $152.6M | $277.9M |
| Other Current Assets | $183K | $382K | $366K |
| **Total Current Assets** | $132.8M | $160.4M | $295.4M |
| Property, Plant & Equipment, Net | $3.73M | $6.20M | $6.42M |
| Other Non-Current Assets | $4.38M | $6.83M | $3.16M |
| **Total Non-Current Assets** | $13.65M | $20.37M | $12.54M |
| **Total Assets** | $146.5M | $180.8M | $307.9M |
| Accounts Payable | $5.94M | $9.24M | $10.95M |
| **Total Current Liabilities** | $33.80M | $40.73M | $56.31M |
| Long-Term Debt | $100.6M | $0 | $207.0M |
| **Total Non-Current Liabilities** | $104.7M | $6.45M | $208.1M |
| **Total Liabilities** | $138.5M | $47.18M | $264.4M |
| **Total Debt (incl. Leases)** | $107.0M | $8.05M | $210.1M |
| Common Stock | $1.0K | $1.0K | $5.0K |
| Retained Earnings | -$246.2M | -$106.1M | -$613.7M |
| **Total Stockholders' Equity** | $7.99M | $133.6M | $43.50M |
| Total Equity | $7.99M | $133.6M | $43.50M |

### Balance Sheet (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $199.5M | $133.3M | $161.7M | $124.2M | $153.1M | $186.6M | $216.5M | $152.6M |
| **Cash & Short-Term Investments** | $199.5M | $133.3M | $161.7M | $124.2M | $153.1M | $186.6M | $216.5M | $152.6M |
| Other Current Assets | $346K | $574K | $262K | $183K | $410K | $283K | $269K | $382K |
| **Total Current Assets** | $206.9M | $142.2M | $171.3M | $132.8M | $161.4M | $194.0M | $223.4M | $160.4M |
| Property, Plant & Equipment, Net | $2.17M | $2.69M | $3.20M | $3.73M | $4.31M | $4.88M | $5.55M | $6.20M |
| Other Non-Current Assets | $7.20M | $4.77M | $4.38M | $4.38M | $5.74M | $6.81M | $6.80M | $6.83M |
| **Total Non-Current Assets** | $13.42M | $12.01M | $12.63M | $13.65M | $16.05M | $18.15M | $19.25M | $20.37M |
| **Total Assets** | $220.3M | $154.2M | $184.0M | $146.5M | $177.5M | $212.1M | $242.6M | $180.8M |
| Accounts Payable | $8.37M | $9.80M | $8.76M | $5.94M | $6.77M | $8.29M | $8.89M | $9.24M |
| **Total Current Liabilities** | $27.30M | $28.06M | $26.51M | $33.80M | $35.98M | $38.94M | $43.64M | $40.73M |
| Long-Term Debt | $276.7M | $176.3M | $175.0M | $100.6M | $99.92M | $99.28M | $98.65M | $0 |
| **Total Non-Current Liabilities** | $278.9M | $179.1M | $178.5M | $104.7M | $104.7M | $104.6M | $104.6M | $6.45M |
| **Total Liabilities** | $306.2M | $207.2M | $205.0M | $138.5M | $140.6M | $143.6M | $148.2M | $47.18M |
| **Total Debt (incl. Leases)** | $281.4M | $181.6M | $180.9M | $107.0M | $106.9M | $106.8M | $106.5M | $8.05M |
| Common Stock | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K |
| Retained Earnings | -$355.0M | -$316.3M | -$279.6M | -$246.2M | -$213.4M | -$178.1M | -$149.4M | -$106.1M |
| **Total Stockholders' Equity** | -$85.88M | -$52.98M | -$21.04M | $7.99M | $36.83M | $68.56M | $94.44M | $133.6M |
| Total Equity | -$85.88M | -$52.98M | -$21.04M | $7.99M | $36.83M | $68.56M | $94.44M | $133.6M |

## Cash Flow Statement

### Cash Flow Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 |
| --- | --- | --- | --- |
| Net Income | -$140.1M | $1.69B | -$241.4M |
| Depreciation & Amortization | $2.48M | $2.29M | $1.19M |
| Stock-Based Compensation | $11.14M | $58.52M | $24.85M |
| Change in Receivables | $200K | -$185K | -$535K |
| Change in Payables | -$3.30M | $17.90M | $2.11M |
| **Operating Cash Flow** | -$129.8M | -$194.4M | -$193.3M |
| Capital Expenditure | -$31K | -$2.60M | -$4.59M |
| **Free Cash Flow** | -$129.8M | -$197.0M | -$197.9M |
| **Investing Cash Flow** | -$28K | -$2.60M | -$4.59M |
| **Financing Cash Flow** | $101.4M | $71.68M | $202.0M |
| **Net Change in Cash** | -$28.38M | -$125.3M | $4.06M |

### Cash Flow Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$38.73M | -$36.65M | -$33.44M | -$32.83M | -$35.26M | -$28.65M | -$43.31M | -$47.87M |
| Depreciation & Amortization | $514K | $523K | $537K | $564K | $582K | $662K | $675K | $689K |
| Stock-Based Compensation | $3.34M | $3.10M | $2.65M | $2.74M | $3.17M | $2.77M | $2.45M | $2.98M |
| Change in Receivables | $0 | $0 | $0 | $0 | $81K | -$81K | $200K | -$85K |
| Change in Payables | -$1.40M | $1.01M | $2.82M | -$829K | -$1.52M | -$600K | -$353K | -$3.12M |
| **Operating Cash Flow** | -$34.60M | -$29.92M | -$38.03M | -$30.12M | -$33.82M | -$29.95M | -$35.90M | -$43.72M |
| Capital Expenditure | -$29K | $0 | $0 | $0 | -$10K | $0 | -$21K | -$16K |
| **Free Cash Flow** | -$34.63M | -$29.92M | -$38.03M | -$30.12M | -$33.83M | -$29.95M | -$35.92M | -$43.74M |
| **Investing Cash Flow** | -$29K | $0 | $0 | $0 | -$7.0K | $0 | -$21K | -$16K |
| **Financing Cash Flow** | $100.8M | $1.60M | $75.46M | $1.25M | $352K | $0 | $99.84M | $0 |
| **Net Change in Cash** | $66.12M | -$28.31M | $37.44M | -$28.87M | -$33.48M | -$29.95M | $63.92M | -$43.74M |

## Profitability Ratios & YoY Growth

### Profitability Ratios & YoY Growth (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 |
| --- | --- | --- | --- |
| **Operating Margin** | -10386.5% | -165724.0% | -12178.9% |
| **Net Profit Margin** | -10773.5% | 843786.0% | -13408.9% |
| Return on Equity (ROE) | -1752.2% | 1263.3% | -554.8% |
| Return on Assets (ROA) | -95.6% | 933.6% | -78.4% |
| Current Ratio | 3.93x | 3.94x | 5.25x |
| Quick Ratio | 3.68x | 3.75x | 4.94x |
| Debt to Equity | 13.39x | 0.06x | 4.83x |
| **Revenue Growth (YoY)** | +550.0% | -88.9% | -- |
| **Net Income Growth (YoY)** | -108.3% | -- | -- |
| EPS Growth (YoY) | -107.9% | -- | -- |

### Profitability Ratios & YoY Growth (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Operating Margin** | -- | -- | -- | -10386.5% | -11002.1% | -11929.6% | -150262.0% | -165724.0% |
| **Net Profit Margin** | -- | -- | -- | -10773.5% | -11077.6% | -11692.4% | 861485.5% | 843786.0% |
| Return on Equity (ROE) | -- | -- | -- | -1752.2% | -421.1% | -238.8% | 1824.4% | 1263.3% |
| Return on Assets (ROA) | -64.3% | -89.6% | -70.8% | -95.6% | -87.4% | -77.2% | 710.1% | 933.6% |
| Current Ratio | 7.58x | 5.07x | 6.46x | 3.93x | 4.49x | 4.98x | 5.12x | 3.94x |
| Quick Ratio | 7.31x | 4.75x | 6.10x | 3.68x | 4.25x | 4.79x | 4.96x | 3.75x |
| Debt to Equity | -- | -- | -- | 13.39x | 2.90x | 1.56x | 1.13x | 0.06x |
| **Revenue Growth (YoY)** | -- | -100.0% | -- | -100.0% | -- | +1200.0% | -- | -- |
| **Net Income Growth (YoY)** | -- | -- | -- | -- | -- | -101.5% | -- | -- |
| EPS Growth (YoY) | -- | -- | -- | -- | -- | -101.5% | -- | -- |

## Related Companies

[AMZN (Amazon.com, Inc.)](https://convexityos.com/fundamentals/AMZN), [WMT (Walmart Inc.)](https://convexityos.com/fundamentals/WMT), [AAPL (Apple Inc.)](https://convexityos.com/fundamentals/AAPL), [GOOG (Alphabet Inc.)](https://convexityos.com/fundamentals/GOOG), [UNH (UnitedHealth Group Incorporated)](https://convexityos.com/fundamentals/UNH), [CVS (CVS HEALTH Corp)](https://convexityos.com/fundamentals/CVS), [MCK (McKESSON CORPORATION)](https://convexityos.com/fundamentals/MCK), [BRK-A (Berkshire Hathaway Inc.)](https://convexityos.com/fundamentals/BRK-A)

---

## About Convexity

Published by [Convexity](https://convexityos.com/), a primary-source financial intelligence terminal built on SEC EDGAR filings, XBRL financial statements, options, macro data, and cited AI research. Free tier with no card and published prices at https://convexityos.com/pricing; Streamable HTTP MCP server at https://convexityos.com/mcp; full site index at https://convexityos.com/llms.txt.
